Review



primary human cardiofibroblasts  (PromoCell)


Bioz Verified Symbol PromoCell is a verified supplier
Bioz Manufacturer Symbol PromoCell manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    PromoCell primary human cardiofibroblasts
    Venn diagram ( A ) of overlapped up- and downregulated genes detected between two cell types (hCF and hCM). Significantly changed genes in hCM ( B ) and hCF ( C ) treated with sera from acute MCD patients vs. healthy controls. Student’ t -test, p FDR < 0.1, n = 3 per group. Abbreviations: hCM, human cardiomyocytes; hCF, human <t>cardiofibroblasts.</t>
    Primary Human Cardiofibroblasts, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 258 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary human cardiofibroblasts/product/PromoCell
    Average 96 stars, based on 258 article reviews
    primary human cardiofibroblasts - by Bioz Stars, 2026-06
    96/100 stars

    Images

    1) Product Images from "Primary Human Cardiomyocytes and Cardiofibroblasts Treated with Sera from Myocarditis Patients Exhibit an Increased Iron Demand and Complex Changes in the Gene Expression"

    Article Title: Primary Human Cardiomyocytes and Cardiofibroblasts Treated with Sera from Myocarditis Patients Exhibit an Increased Iron Demand and Complex Changes in the Gene Expression

    Journal: Cells

    doi: 10.3390/cells10040818

    Venn diagram ( A ) of overlapped up- and downregulated genes detected between two cell types (hCF and hCM). Significantly changed genes in hCM ( B ) and hCF ( C ) treated with sera from acute MCD patients vs. healthy controls. Student’ t -test, p FDR < 0.1, n = 3 per group. Abbreviations: hCM, human cardiomyocytes; hCF, human cardiofibroblasts.
    Figure Legend Snippet: Venn diagram ( A ) of overlapped up- and downregulated genes detected between two cell types (hCF and hCM). Significantly changed genes in hCM ( B ) and hCF ( C ) treated with sera from acute MCD patients vs. healthy controls. Student’ t -test, p FDR < 0.1, n = 3 per group. Abbreviations: hCM, human cardiomyocytes; hCF, human cardiofibroblasts.

    Techniques Used:

    Selected hints of the significantly dysregulated canonical pathways in hCM ( A ) and hCF ( B ) treated with sera from acute MCD patients vs. healthy controls. Selected hints of the significantly dysregulated cardiotoxicity functions in hCM ( C ) and hCF ( D ) treated with sera from acute MCD patients vs. healthy controls. Identified with Ingenuity Pathway Analysis (IPA) using respectively 1138 and 1050 protein-coding transcripts that changed significantly. Fisher’s exact test, p < 0.05. Abbreviations: hCM, human cardiomyocytes; hCF, human cardiofibroblasts; ERK5, extracellular-signal-regulated kinase 5; iNOS, inducible nitric oxide synthase; PAK, p21-activated kinases; GM-CSF, granulocyte-macrophage colony-stimulating factor; IL-7, interleukin 7; STAT3, signal transducer and activator of transcription 3; IL-6, interleukin 6.
    Figure Legend Snippet: Selected hints of the significantly dysregulated canonical pathways in hCM ( A ) and hCF ( B ) treated with sera from acute MCD patients vs. healthy controls. Selected hints of the significantly dysregulated cardiotoxicity functions in hCM ( C ) and hCF ( D ) treated with sera from acute MCD patients vs. healthy controls. Identified with Ingenuity Pathway Analysis (IPA) using respectively 1138 and 1050 protein-coding transcripts that changed significantly. Fisher’s exact test, p < 0.05. Abbreviations: hCM, human cardiomyocytes; hCF, human cardiofibroblasts; ERK5, extracellular-signal-regulated kinase 5; iNOS, inducible nitric oxide synthase; PAK, p21-activated kinases; GM-CSF, granulocyte-macrophage colony-stimulating factor; IL-7, interleukin 7; STAT3, signal transducer and activator of transcription 3; IL-6, interleukin 6.

    Techniques Used:

    The expression of TFR1 in human cardiomyocytes ( A – C ) and in human cardiofibroblasts ( D – F ) treated with patients’ sera at the mRNA and protein level, together with representative immunoblots ( C , F ). ANNOVA test followed by Dunnett’s multiple comparisons test or Kruskal–Wallis test followed by Dunn’s multiple comparisons test (depending on data normality). * p < 0.05; ** p < 0.01; *** p < 0.001. The association between the protein level of TFR1 in human cardiac myocytes treated with patient sera and markers of iron status in patients’ peripheral blood i.e., transferrin saturation ( G ), serum iron ( H ), and serum ferritin ( I ). Gene and protein expressions were normalized to mean value in control group. Spearman’s rank correlation. * p < 0.05; ** p < 0.01; *** p < 0.001. Abbreviations: AU, arbitrary units; C, healthy controls, H, hospitalization (acute phase); 6wk, after 6 weeks of clinical recovery; TFR1, transferrin receptor 1; TSAT, transferrin saturation.
    Figure Legend Snippet: The expression of TFR1 in human cardiomyocytes ( A – C ) and in human cardiofibroblasts ( D – F ) treated with patients’ sera at the mRNA and protein level, together with representative immunoblots ( C , F ). ANNOVA test followed by Dunnett’s multiple comparisons test or Kruskal–Wallis test followed by Dunn’s multiple comparisons test (depending on data normality). * p < 0.05; ** p < 0.01; *** p < 0.001. The association between the protein level of TFR1 in human cardiac myocytes treated with patient sera and markers of iron status in patients’ peripheral blood i.e., transferrin saturation ( G ), serum iron ( H ), and serum ferritin ( I ). Gene and protein expressions were normalized to mean value in control group. Spearman’s rank correlation. * p < 0.05; ** p < 0.01; *** p < 0.001. Abbreviations: AU, arbitrary units; C, healthy controls, H, hospitalization (acute phase); 6wk, after 6 weeks of clinical recovery; TFR1, transferrin receptor 1; TSAT, transferrin saturation.

    Techniques Used: Expressing, Western Blot



    Similar Products

    96
    PromoCell primary human cardiofibroblasts
    Venn diagram ( A ) of overlapped up- and downregulated genes detected between two cell types (hCF and hCM). Significantly changed genes in hCM ( B ) and hCF ( C ) treated with sera from acute MCD patients vs. healthy controls. Student’ t -test, p FDR < 0.1, n = 3 per group. Abbreviations: hCM, human cardiomyocytes; hCF, human <t>cardiofibroblasts.</t>
    Primary Human Cardiofibroblasts, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary human cardiofibroblasts/product/PromoCell
    Average 96 stars, based on 1 article reviews
    primary human cardiofibroblasts - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    Image Search Results


    Venn diagram ( A ) of overlapped up- and downregulated genes detected between two cell types (hCF and hCM). Significantly changed genes in hCM ( B ) and hCF ( C ) treated with sera from acute MCD patients vs. healthy controls. Student’ t -test, p FDR < 0.1, n = 3 per group. Abbreviations: hCM, human cardiomyocytes; hCF, human cardiofibroblasts.

    Journal: Cells

    Article Title: Primary Human Cardiomyocytes and Cardiofibroblasts Treated with Sera from Myocarditis Patients Exhibit an Increased Iron Demand and Complex Changes in the Gene Expression

    doi: 10.3390/cells10040818

    Figure Lengend Snippet: Venn diagram ( A ) of overlapped up- and downregulated genes detected between two cell types (hCF and hCM). Significantly changed genes in hCM ( B ) and hCF ( C ) treated with sera from acute MCD patients vs. healthy controls. Student’ t -test, p FDR < 0.1, n = 3 per group. Abbreviations: hCM, human cardiomyocytes; hCF, human cardiofibroblasts.

    Article Snippet: Primary human cardiofibroblasts (hCF, PromoCell) were precultured in Fibroblast Growth Medium supplemented with the recommended Supplemented Mix (PromoCell) and passaged 5 times before the experiment.

    Techniques:

    Selected hints of the significantly dysregulated canonical pathways in hCM ( A ) and hCF ( B ) treated with sera from acute MCD patients vs. healthy controls. Selected hints of the significantly dysregulated cardiotoxicity functions in hCM ( C ) and hCF ( D ) treated with sera from acute MCD patients vs. healthy controls. Identified with Ingenuity Pathway Analysis (IPA) using respectively 1138 and 1050 protein-coding transcripts that changed significantly. Fisher’s exact test, p < 0.05. Abbreviations: hCM, human cardiomyocytes; hCF, human cardiofibroblasts; ERK5, extracellular-signal-regulated kinase 5; iNOS, inducible nitric oxide synthase; PAK, p21-activated kinases; GM-CSF, granulocyte-macrophage colony-stimulating factor; IL-7, interleukin 7; STAT3, signal transducer and activator of transcription 3; IL-6, interleukin 6.

    Journal: Cells

    Article Title: Primary Human Cardiomyocytes and Cardiofibroblasts Treated with Sera from Myocarditis Patients Exhibit an Increased Iron Demand and Complex Changes in the Gene Expression

    doi: 10.3390/cells10040818

    Figure Lengend Snippet: Selected hints of the significantly dysregulated canonical pathways in hCM ( A ) and hCF ( B ) treated with sera from acute MCD patients vs. healthy controls. Selected hints of the significantly dysregulated cardiotoxicity functions in hCM ( C ) and hCF ( D ) treated with sera from acute MCD patients vs. healthy controls. Identified with Ingenuity Pathway Analysis (IPA) using respectively 1138 and 1050 protein-coding transcripts that changed significantly. Fisher’s exact test, p < 0.05. Abbreviations: hCM, human cardiomyocytes; hCF, human cardiofibroblasts; ERK5, extracellular-signal-regulated kinase 5; iNOS, inducible nitric oxide synthase; PAK, p21-activated kinases; GM-CSF, granulocyte-macrophage colony-stimulating factor; IL-7, interleukin 7; STAT3, signal transducer and activator of transcription 3; IL-6, interleukin 6.

    Article Snippet: Primary human cardiofibroblasts (hCF, PromoCell) were precultured in Fibroblast Growth Medium supplemented with the recommended Supplemented Mix (PromoCell) and passaged 5 times before the experiment.

    Techniques:

    The expression of TFR1 in human cardiomyocytes ( A – C ) and in human cardiofibroblasts ( D – F ) treated with patients’ sera at the mRNA and protein level, together with representative immunoblots ( C , F ). ANNOVA test followed by Dunnett’s multiple comparisons test or Kruskal–Wallis test followed by Dunn’s multiple comparisons test (depending on data normality). * p < 0.05; ** p < 0.01; *** p < 0.001. The association between the protein level of TFR1 in human cardiac myocytes treated with patient sera and markers of iron status in patients’ peripheral blood i.e., transferrin saturation ( G ), serum iron ( H ), and serum ferritin ( I ). Gene and protein expressions were normalized to mean value in control group. Spearman’s rank correlation. * p < 0.05; ** p < 0.01; *** p < 0.001. Abbreviations: AU, arbitrary units; C, healthy controls, H, hospitalization (acute phase); 6wk, after 6 weeks of clinical recovery; TFR1, transferrin receptor 1; TSAT, transferrin saturation.

    Journal: Cells

    Article Title: Primary Human Cardiomyocytes and Cardiofibroblasts Treated with Sera from Myocarditis Patients Exhibit an Increased Iron Demand and Complex Changes in the Gene Expression

    doi: 10.3390/cells10040818

    Figure Lengend Snippet: The expression of TFR1 in human cardiomyocytes ( A – C ) and in human cardiofibroblasts ( D – F ) treated with patients’ sera at the mRNA and protein level, together with representative immunoblots ( C , F ). ANNOVA test followed by Dunnett’s multiple comparisons test or Kruskal–Wallis test followed by Dunn’s multiple comparisons test (depending on data normality). * p < 0.05; ** p < 0.01; *** p < 0.001. The association between the protein level of TFR1 in human cardiac myocytes treated with patient sera and markers of iron status in patients’ peripheral blood i.e., transferrin saturation ( G ), serum iron ( H ), and serum ferritin ( I ). Gene and protein expressions were normalized to mean value in control group. Spearman’s rank correlation. * p < 0.05; ** p < 0.01; *** p < 0.001. Abbreviations: AU, arbitrary units; C, healthy controls, H, hospitalization (acute phase); 6wk, after 6 weeks of clinical recovery; TFR1, transferrin receptor 1; TSAT, transferrin saturation.

    Article Snippet: Primary human cardiofibroblasts (hCF, PromoCell) were precultured in Fibroblast Growth Medium supplemented with the recommended Supplemented Mix (PromoCell) and passaged 5 times before the experiment.

    Techniques: Expressing, Western Blot